Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series

Abstract

Abstract Most of the post‐renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti‐proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post‐renal transplant patients with severe COVID‐19 infection admitted to the intensive care unit.

Keywords

• acute kidney injury
• COVID‐19 infection
• end‐stage renal disease
• hypertension
• immunosuppression
• renal transplant